Morgan Stanley »

Intra Cellular Therapies shares owned by Morgan Stanley

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $65M 940k 69.20
2023-09-30 $49M 936k 52.09
2023-06-30 $65M 1.0M 63.32
2022-12-31 $51M 960k 52.88
2022-06-30 $44M 778k 56.80
2022-03-31 $40M 654k 61.15
2021-06-30 $27M 663k 40.85
2020-12-31 $15M 480k 31.80
2020-09-30 $13M 507k 25.69
2020-06-30 $13M 508k 25.68
2020-03-31 $8.3M 541k 15.36
2019-12-31 $31M 907k 34.31
2019-09-30 $6.0M 798k 7.47
2019-03-31 $5.6M 457k 12.17
2018-12-31 $5.8M 511k 11.39
2018-09-30 $13M 579k 21.70
2018-06-30 $11M 582k 18.23
2018-03-31 $12M 589k 21.05
2017-12-31 $7.7M 532k 14.48
2017-03-31 $7.0M 432k 16.25
2016-12-31 $7.4M 492k 15.09
2016-09-30 $6.8M 446k 15.21
2016-06-30 $16M 415k 39.00
2016-03-31 $0 406k 0.00
2015-12-31 $0 356k 0.00
2015-09-30 $23M 573k 40.04
2015-06-30 $12M 378k 31.94
2014-12-31 $4.7M 258k 18.04
2014-09-30 $3.1M 228k 13.48
2014-06-30 $4.2M 242k 17.23
2014-03-31 $2.6M 123k 21.05